OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Jianan Huang, College of Pharmaceutical Sciences, Zhejiang University, China.
Jianan Huang outlines the market prospects for first-line treatments for liver cancer treatment in China.
Jianan Huang discusses how the drug revenue formula is being used to guide R&D "rescue strategies".
Joanna Huang analyses the use of external innovation tools among small and large pharma in China.